IT4Anxiety

 

 

 

IT4Anxiety aims to support the implementation of innovative solutions through start-ups with the objective of reducing the anxiety of patients suffering from mental disorders.

Technological innovations give new perspectives in many domains, including health. It was in this context that the IT4Anxiety project (funded by Interreg Europe) was born bringing together mental health professionals and startups, but also universities, research centers, higher education establishments, public authorities and GAMIAN Europe representing the patients.

The project focuses more specifically on the creation and implementation of innovative solutions, in particular those related to digital technology, with the objective of reducing the anxiety of patients suffering from neurodegenerative diseases (e.g. Alzheimer‘s disease) or post-traumatic stress disorder. These mental illnesses affect a growing number of patients in North-West Europe, due to ageing population trends.

 

 

Duration 

4 years | 2019-2023

Partners

10

Countries

6

LEARN MORE ON THIS TOPIC

Related Blog Posts

Unmet Needs and Opportunities of Psychopharmacology in Chidren & Adolescents: The Lancet Psychiatry Position Paper is out!

The Lancet Psychiatry Journal published on 7 December, 2023 its position paper “Psychopharmacology in Chilrden and Adolescents : Unmet needs and opportunities”. It focuses on psychopharmacology in children and adolescents, discussing the unmet needs and opportunities in this area, highlighting current challenges and potential advancements in treating mental health conditions.